Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

Sirolimus is an effective agent used in graft-versus-host disease (GVHD) prophylaxis after allogeneic transplantation. It also has antiproliferative effects on vascular endothelium when used to coat coronary artery stents. We noted an excess of veno-occlusive disease (VOD) in a clinical trial, and r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cutler, Corey, Stevenson, Kristen, Kim, Haesook T., Richardson, Paul, Ho, Vincent T., Linden, Erica, Revta, Carolyn, Ebert, Ruth, Warren, Diane, Choi, Sung, Koreth, John, Armand, Philippe, Alyea, Edwin, Carter, Shelly, Horowitz, Mary, Antin, Joseph H., Soiffer, Robert
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2008
Aiheet:
Clinical Trials and Observations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2597119/
https://ncbi.nlm.nih.gov/pubmed/18776081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-169342
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia